4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-142137
Chief Financial Officer sold 5,727 shares at $18.64 ($106,751)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lucera Erick · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-01 | Sale : show line 1 in the form 10b5-1 | −5,727 | $18.64 | $106,751 | 125,373 | D |
| Open-market sales · 5,727 sh · avg $18.64 · $106,751 | ||||||
Loading xslF345X06/ownership.xml…